Akston Biosciences Corporation: Akston Biosciences Doses Fir

Up to 600 volunteers will participate in an AKS-452 COVID booster study in the Netherlands to investigate boosting the immune response of those previously vaccinated with EMA-registered vaccines

Related Keywords

India , Netherlands , Groningen , Linda Pendergast , Todd Zion , Schelto Kruijff , Kostenloser Wertpapierhandel , Johnson Janssen , Akston Biosciences , Akston Bioscience , Akston Biosciences Corporation , Birnbach Communications For Akston Biosciences , Merck Co , University Medical Center Groningen , Pfizer , Dechra Pharmaceuticals , Astrazeneca , Clinical Research Organization , Smartcells Inc , Rapid Cure Task Force , Emergency Use Authorization , Biosciences Corporation , Johnson , Business Wire , Receptor Binding Domain , Cure Task Force , Akston , Iosciences , Corporation , Doses , First , Participants , Hase , Linical , Trial , Shelf , Table , Covid , Rooster ,